These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15175360)

  • 1. The APOA4 T347S variant is associated with reduced plasma TAOS in subjects with diabetes mellitus and cardiovascular disease.
    Wong WM; Stephens JW; Acharya J; Hurel SJ; Humphries SE; Talmud PJ
    J Lipid Res; 2004 Aug; 45(8):1565-71. PubMed ID: 15175360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels.
    Wong WM; Hawe E; Li LK; Miller GJ; Nicaud V; Pennacchio LA; Humphries SE; Talmud PJ
    Circ Res; 2003 May; 92(9):969-75. PubMed ID: 12676816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation.
    Wong WM; Gerry AB; Putt W; Roberts JL; Weinberg RB; Humphries SE; Leake DS; Talmud PJ
    Atherosclerosis; 2007 Jun; 192(2):266-74. PubMed ID: 16945374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the apoA-IV T347S and Q360H common variants.
    Gomaraschi M; Putt WE; Pozzi S; Iametti S; Barbiroli A; Bonomi F; Favari E; Bernini F; Franceschini G; Talmud PJ; Calabresi L
    Biochem Biophys Res Commun; 2010 Feb; 393(1):126-30. PubMed ID: 20117098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common deletion polymorphism in the apolipoprotein A4 gene and its significance in lipid metabolism.
    Kamboh MI; Friedlaender JS; Ahn YI; Ferrell RE
    Arterioscler Thromb; 1994 May; 14(5):656-62. PubMed ID: 8172842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women.
    Guclu-Geyik F; Onat A; Coban N; Komurcu-Bayrak E; Sansoy V; Can G; Erginel-Unaltuna N
    Mol Biol Rep; 2012 Dec; 39(12):10907-14. PubMed ID: 23096082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
    Talmud PJ; Hawe E; Martin S; Olivier M; Miller GJ; Rubin EM; Pennacchio LA; Humphries SE
    Hum Mol Genet; 2002 Nov; 11(24):3039-46. PubMed ID: 12417525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation at the apoA-IV gene locus and response to diet in familial hypercholesterolemia.
    Carmena-Ramón R; Ascaso JF; Real JT; Ordovas JM; Carmena R
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1266-74. PubMed ID: 9714133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice.
    Ostos MA; Conconi M; Vergnes L; Baroukh N; Ribalta J; Girona J; Caillaud JM; Ochoa A; Zakin MM
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1023-8. PubMed ID: 11397714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2.
    Dhamrait SS; Stephens JW; Cooper JA; Acharya J; Mani AR; Moore K; Miller GJ; Humphries SE; Hurel SJ; Montgomery HE
    Eur Heart J; 2004 Mar; 25(6):468-75. PubMed ID: 15039126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes.
    Dai Y; Shen Y; Li QR; Ding FH; Wang XQ; Liu HJ; Yan XX; Wang LJ; Yang K; Wang HB; Chen QJ; Shen WF; Zhang RY; Lu L
    J Am Coll Cardiol; 2017 Oct; 70(16):2006-2019. PubMed ID: 29025558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 360His polymorphism of the apolipoproteinA-IV gene and plasma lipid response to energy restricted diets in overweight subjects.
    Heilbronn LK; Noakes M; Morris AM; Kind KL; Clifton PM
    Atherosclerosis; 2000 May; 150(1):187-92. PubMed ID: 10781650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes.
    Kretowski A; Hokanson JE; McFann K; Kinney GL; Snell-Bergeon JK; Maahs DM; Wadwa RP; Eckel RH; Ogden LG; Garg SK; Li J; Cheng S; Erlich HA; Rewers M
    Diabetologia; 2006 Aug; 49(8):1946-54. PubMed ID: 16770585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urbanization elicits a more atherogenic lipoprotein profile in carriers of the apolipoprotein A-IV-2 allele than in A-IV-1 homozygotes.
    Campos H; López-Miranda J; Rodríguez C; Albajar M; Schaefer EJ; Ordovás JM
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1074-81. PubMed ID: 9194757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males.
    Stephens JW; Gable DR; Hurel SJ; Miller GJ; Cooper JA; Humphries SE
    Clin Chem; 2006 Mar; 52(3):446-52. PubMed ID: 16384883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of cationized LDL cholesterol from a muscle depot is not enhanced in human apolipoprotein A-IV transgenic mice.
    Stein Y; Stein O; Duverger N; Halperin G; Dabach Y; Hollander G; Ben-Naim M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):179-84. PubMed ID: 10634815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study.
    Kollerits B; Krane V; Drechsler C; Lamina C; März W; Ritz E; Wanner C; Kronenberg F;
    J Intern Med; 2012 Dec; 272(6):592-600. PubMed ID: 22891946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes.
    Qu J; Ko CW; Tso P; Bhargava A
    Cells; 2019 Apr; 8(4):. PubMed ID: 30959835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
    Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
    Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort.
    Prior SL; Tang TS; Gill GV; Bain SC; Stephens JW
    Metabolism; 2011 Feb; 60(2):173-9. PubMed ID: 20188385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.